Intellectual property law

Intellectual property law

Ruling partially favors plaintiffs in copyright infringement case against OpenAI and Microsoft, highlighting credible allegations of content misuse.

The Indian art world is embroiled in a controversy over alleged copyright infringement involving Anita Dube and poet Aamir Aziz.

The dismissal of IP law by tech leaders ignores its vital role in innovation and commerce.

Jack Dorsey and Elon Musk's call to 'delete all IP law' raises concerns about intellectual property rights and creative incentives.

IP laws are seen by some as barriers that protect monopolies rather than fostering innovation or competition.

CAFC reversed PTAB ruling, stating AAPA cannot be solely used as a basis in determining patent unpatentability.

Lost profit damages for patent infringement can include profits from unpatented products when they are functioning components of a patented product.

The concept of PHOSITA in patent law is increasingly unrealistic, affecting fairness and predictability.

The Federal Circuit highlights the implications of statutory estoppel in patent challenge proceedings under 35 U.S.C. § 315(e)(1).

Prosecution laches may render patents unenforceable despite adherence to timelines, contradicting statutory protections.

The Federal Circuit clarified the distinction between apportionment and convoyed sales in patent damages, reducing a jury's award significantly.

The USPTO's new patent issuance timeline significantly enhances efficiency for inventors and patent holders.

The USPTO established a working group to mitigate patent fraud, enhancing the integrity of the patent system.

The new interim procedure changes how discretionary denials are handled in IPR proceedings, focusing solely on those issues before the main merits are debated.

USPTO has reversed course on discretionary denials, influenced by workforce changes and the Fintiv framework.

The USPTO has introduced interim procedures for PTAB workload management to enhance efficiency and decision quality.

Acting USPTO Director Stewart's decision signals increased discretionary denials for inter partes reviews based on case specifics.

Cellspin Soft argues that due process errors involving recusal based on financial conflicts are structural and thus, cannot be considered harmless.

The case Xerox v. Facebook raises questions about the PTAB's adherence to district court claim constructions, invoking judicial review's principles from Marbury v. Madison.

Burden of proof in patent enablement lies with the challenger, yet strong presumption of enabling prior art shifts duty to patentee.

Emily Ley's lawsuit challenges Trump's tariffs as harmful and unlawful, representing the struggles of small businesses impacted by international trade policies.

HP agrees to pay $4 million to settle a class-action lawsuit over deceptive pricing tactics, but denies any wrongdoing.

Prejudgment interest should start from the date of actual financial injury, not just when the lawsuit was filed.

Lawyers can misuse cases in many ways, but copying public filings is not one of them.

No one can own the law, ensuring public access to essential safety regulations.

The EFF argues that the Kadrey v. Meta case may undermine fair use defense for AI developers by challenging how training materials were obtained.

UK authors protest against Meta's alleged copyright infringement involving AI training datasets.

Thomson Reuters won a partial summary judgment against Ross Intelligence for unauthorized use of copyrighted Westlaw content.

Kelley Heyer has sued Roblox for using her copyrighted dance without finalizing a license agreement.

Proposed copyright law overhaul threatens UK design industry, say leading designers.

ROSS Intelligence challenges copyright rulings by Judge Bibas on originality and fair use regarding legal research materials in a bid for an interlocutory appeal.

PatCon 13 is the largest annual patent conference, featuring keynotes and awards for leaders in patent law.

The event is free for academics, students, and government attorneys.

The Federal Circuit affirmed the invalidation of three AliveCor patents, impacting AliveCor's market position.

The courts are correctly applying the evidentiary burden for determining patent eligibility under the Alice standard.

NIH faces lawsuits over cancelled grants and delays due to Trump's executive order targeting diversity-related funding.

NIH's funding cap for indirect research costs faces legal challenges and significant pushback from academic institutions.

Congress is reviewing drug patent regulation legislation based on refuted data.

The Center for American Principles warns against bills influenced by misleading drug market data.

Senator Lee expressed concerns over proposed drug patent bills potentially undermining due process while addressing drug pricing issues.